Cogent's New Stomach Cancer Treatment Cuts Progression Risk In Half, Gets Breakthrough Therapy Tag
Cogent Biosciences, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $34.81
+12% in 7d after detection
Post-detection moves
1h
—
1d
+5.4%
3d
+4.5%
7d
+12%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS